Melanoma, Secondary cancers
Results
Pilot
This trial looked at whether measuring can help doctors decide when to change from targeted treatment to immunotherapy.
It was for people with melanoma which:
couldn’t be removed with surgery, or had spread elsewhere in the body
had a specific change in the BRAF called BRAF V600E
People could join this study between 2019 and 2022. The team analysed the results in 2023.
Recruitment start: 2 May 2019
Recruitment end: 30 September 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Paul Lorigan
Bristol-Myers Squibb
The Christie NHS Foundation Trust
University of Manchester
Last reviewed: 04 Feb 2026
CRUK internal database number: 17883
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
